Report Detail
Global and Japan Oncology Injection Drug Market Insights, Forecast to 2026
- RnM4175754 |
- 31 August, 2020 |
- Global |
- 146 Pages |
- QYResearch |
- Chemical & Material
Oncology Injection Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Oncology Injection Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Oncology Injection Drug market is segmented into
Organs
Central Nervous System
Circulatory/Musculoskeletal System
Other
Segment by Application, the Oncology Injection Drug market is segmented into
Lymphoma
Myeloma
Prostate Cancer
Other
Regional and Country-level Analysis
The Oncology Injection Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Oncology Injection Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Oncology Injection Drug Market Share Analysis
Oncology Injection Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Oncology Injection Drug business, the date to enter into the Oncology Injection Drug market, Oncology Injection Drug product introduction, recent developments, etc.
The major vendors covered:
Taj Oncology
S.G. Biopharm
AdvaCare
Merrimack
Celgene
Allos Therapeutics
Ferring Pharmaceuticals
Genzyme
Eli Lilly
Praecis Pharmaceuticals
Millennium Pharmaceuticals
Debiopharm
Alza
CordenPharma
Pharmascience
1 Study Coverage
- 1.1 Oncology Injection Drug Product Introduction
- 1.2 Market Segments
- 1.3 Key Oncology Injection Drug Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Oncology Injection Drug Market Size Growth Rate by Type
- 1.4.2 Organs
- 1.4.3 Central Nervous System
- 1.4.4 Circulatory/Musculoskeletal System
- 1.4.5 Other
- 1.5 Market by Application
- 1.5.1 Global Oncology Injection Drug Market Size Growth Rate by Application
- 1.5.2 Lymphoma
- 1.5.3 Myeloma
- 1.5.4 Prostate Cancer
- 1.5.5 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Oncology Injection Drug Market Size, Estimates and Forecasts
- 2.1.1 Global Oncology Injection Drug Revenue 2015-2026
- 2.1.2 Global Oncology Injection Drug Sales 2015-2026
- 2.2 Global Oncology Injection Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.3 Oncology Injection Drug Historical Market Size by Region (2015-2020)
- 2.3.1 Global Oncology Injection Drug Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.3.2 Global Oncology Injection Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
- 2.4 Oncology Injection Drug Market Estimates and Projections by Region (2021-2026)
- 2.4.1 Global Oncology Injection Drug Sales Forecast by Region (2021-2026)
- 2.4.2 Global Oncology Injection Drug Revenue Forecast by Region (2021-2026)
3 Global Oncology Injection Drug Competitor Landscape by Players
- 3.1 Global Top Oncology Injection Drug Sales by Manufacturers
- 3.1.1 Global Oncology Injection Drug Sales by Manufacturers (2015-2020)
- 3.1.2 Global Oncology Injection Drug Sales Market Share by Manufacturers (2015-2020)
- 3.2 Global Oncology Injection Drug Manufacturers by Revenue
- 3.2.1 Global Oncology Injection Drug Revenue by Manufacturers (2015-2020)
- 3.2.2 Global Oncology Injection Drug Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Oncology Injection Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Oncology Injection Drug Revenue in 2019
- 3.2.5 Global Oncology Injection Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Global Oncology Injection Drug Price by Manufacturers
- 3.4 Global Oncology Injection Drug Manufacturing Base Distribution, Product Types
- 3.4.1 Oncology Injection Drug Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Oncology Injection Drug Product Type
- 3.4.3 Date of International Manufacturers Enter into Oncology Injection Drug Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Oncology Injection Drug Market Size by Type (2015-2020)
- 4.1.1 Global Oncology Injection Drug Sales by Type (2015-2020)
- 4.1.2 Global Oncology Injection Drug Revenue by Type (2015-2020)
- 4.1.3 Oncology Injection Drug Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Oncology Injection Drug Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Oncology Injection Drug Sales Forecast by Type (2021-2026)
- 4.2.2 Global Oncology Injection Drug Revenue Forecast by Type (2021-2026)
- 4.2.3 Oncology Injection Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Oncology Injection Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Oncology Injection Drug Market Size by Application (2015-2020)
- 5.1.1 Global Oncology Injection Drug Sales by Application (2015-2020)
- 5.1.2 Global Oncology Injection Drug Revenue by Application (2015-2020)
- 5.1.3 Oncology Injection Drug Price by Application (2015-2020)
- 5.2 Oncology Injection Drug Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Oncology Injection Drug Sales Forecast by Application (2021-2026)
- 5.2.2 Global Oncology Injection Drug Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Oncology Injection Drug Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
- 6.1 Japan Oncology Injection Drug Market Size YoY Growth 2015-2026
- 6.1.1 Japan Oncology Injection Drug Sales YoY Growth 2015-2026
- 6.1.2 Japan Oncology Injection Drug Revenue YoY Growth 2015-2026
- 6.1.3 Japan Oncology Injection Drug Market Share in Global Market 2015-2026
- 6.2 Japan Oncology Injection Drug Market Size by Players (International and Local Players)
- 6.2.1 Japan Top Oncology Injection Drug Players by Sales (2015-2020)
- 6.2.2 Japan Top Oncology Injection Drug Players by Revenue (2015-2020)
- 6.3 Japan Oncology Injection Drug Historic Market Review by Type (2015-2020)
- 6.3.1 Japan Oncology Injection Drug Sales Market Share by Type (2015-2020)
- 6.3.2 Japan Oncology Injection Drug Revenue Market Share by Type (2015-2020)
- 6.3.3 Japan Oncology Injection Drug Price by Type (2015-2020)
- 6.4 Japan Oncology Injection Drug Market Estimates and Forecasts by Type (2021-2026)
- 6.4.1 Japan Oncology Injection Drug Sales Forecast by Type (2021-2026)
- 6.4.2 Japan Oncology Injection Drug Revenue Forecast by Type (2021-2026)
- 6.4.3 Japan Oncology Injection Drug Price Forecast by Type (2021-2026)
- 6.5 Japan Oncology Injection Drug Historic Market Review by Application (2015-2020)
- 6.5.1 Japan Oncology Injection Drug Sales Market Share by Application (2015-2020)
- 6.5.2 Japan Oncology Injection Drug Revenue Market Share by Application (2015-2020)
- 6.5.3 Japan Oncology Injection Drug Price by Application (2015-2020)
- 6.6 Japan Oncology Injection Drug Market Estimates and Forecasts by Application (2021-2026)
- 6.6.1 Japan Oncology Injection Drug Sales Forecast by Application (2021-2026)
- 6.6.2 Japan Oncology Injection Drug Revenue Forecast by Application (2021-2026)
- 6.6.3 Japan Oncology Injection Drug Price Forecast by Application (2021-2026)
7 North America
- 7.1 North America Oncology Injection Drug Market Size YoY Growth 2015-2026
- 7.2 North America Oncology Injection Drug Market Facts & Figures by Country
- 7.2.1 North America Oncology Injection Drug Sales by Country (2015-2020)
- 7.2.2 North America Oncology Injection Drug Revenue by Country (2015-2020)
- 7.2.3 U.S.
- 7.2.4 Canada
8 Europe
- 8.1 Europe Oncology Injection Drug Market Size YoY Growth 2015-2026
- 8.2 Europe Oncology Injection Drug Market Facts & Figures by Country
- 8.2.1 Europe Oncology Injection Drug Sales by Country
- 8.2.2 Europe Oncology Injection Drug Revenue by Country
- 8.2.3 Germany
- 8.2.4 France
- 8.2.5 U.K.
- 8.2.6 Italy
- 8.2.7 Russia
9 Asia Pacific
- 9.1 Asia Pacific Oncology Injection Drug Market Size YoY Growth 2015-2026
- 9.2 Asia Pacific Oncology Injection Drug Market Facts & Figures by Country
- 9.2.1 Asia Pacific Oncology Injection Drug Sales by Region (2015-2020)
- 9.2.2 Asia Pacific Oncology Injection Drug Revenue by Region
- 9.2.3 China
- 9.2.4 Japan
- 9.2.5 South Korea
- 9.2.6 India
- 9.2.7 Australia
- 9.2.8 Taiwan
- 9.2.9 Indonesia
- 9.2.10 Thailand
- 9.2.11 Malaysia
- 9.2.12 Philippines
- 9.2.13 Vietnam
10 Latin America
- 10.1 Latin America Oncology Injection Drug Market Size YoY Growth 2015-2026
- 10.2 Latin America Oncology Injection Drug Market Facts & Figures by Country
- 10.2.1 Latin America Oncology Injection Drug Sales by Country
- 10.2.2 Latin America Oncology Injection Drug Revenue by Country
- 10.2.3 Mexico
- 10.2.4 Brazil
- 10.2.5 Argentina
11 Middle East and Africa
- 11.1 Middle East and Africa Oncology Injection Drug Market Size YoY Growth 2015-2026
- 11.2 Middle East and Africa Oncology Injection Drug Market Facts & Figures by Country
- 11.2.1 Middle East and Africa Oncology Injection Drug Sales by Country
- 11.2.2 Middle East and Africa Oncology Injection Drug Revenue by Country
- 11.2.3 Turkey
- 11.2.4 Saudi Arabia
- 11.2.5 U.A.E
12 Company Profiles
- 12.1 Taj Oncology
- 12.1.1 Taj Oncology Corporation Information
- 12.1.2 Taj Oncology Description and Business Overview
- 12.1.3 Taj Oncology Sales, Revenue and Gross Margin (2015-2020)
- 12.1.4 Taj Oncology Oncology Injection Drug Products Offered
- 12.1.5 Taj Oncology Recent Development
- 12.2 S.G. Biopharm
- 12.2.1 S.G. Biopharm Corporation Information
- 12.2.2 S.G. Biopharm Description and Business Overview
- 12.2.3 S.G. Biopharm Sales, Revenue and Gross Margin (2015-2020)
- 12.2.4 S.G. Biopharm Oncology Injection Drug Products Offered
- 12.2.5 S.G. Biopharm Recent Development
- 12.3 AdvaCare
- 12.3.1 AdvaCare Corporation Information
- 12.3.2 AdvaCare Description and Business Overview
- 12.3.3 AdvaCare Sales, Revenue and Gross Margin (2015-2020)
- 12.3.4 AdvaCare Oncology Injection Drug Products Offered
- 12.3.5 AdvaCare Recent Development
- 12.4 Merrimack
- 12.4.1 Merrimack Corporation Information
- 12.4.2 Merrimack Description and Business Overview
- 12.4.3 Merrimack Sales, Revenue and Gross Margin (2015-2020)
- 12.4.4 Merrimack Oncology Injection Drug Products Offered
- 12.4.5 Merrimack Recent Development
- 12.5 Celgene
- 12.5.1 Celgene Corporation Information
- 12.5.2 Celgene Description and Business Overview
- 12.5.3 Celgene Sales, Revenue and Gross Margin (2015-2020)
- 12.5.4 Celgene Oncology Injection Drug Products Offered
- 12.5.5 Celgene Recent Development
- 12.6 Allos Therapeutics
- 12.6.1 Allos Therapeutics Corporation Information
- 12.6.2 Allos Therapeutics Description and Business Overview
- 12.6.3 Allos Therapeutics Sales, Revenue and Gross Margin (2015-2020)
- 12.6.4 Allos Therapeutics Oncology Injection Drug Products Offered
- 12.6.5 Allos Therapeutics Recent Development
- 12.7 Ferring Pharmaceuticals
- 12.7.1 Ferring Pharmaceuticals Corporation Information
- 12.7.2 Ferring Pharmaceuticals Description and Business Overview
- 12.7.3 Ferring Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 12.7.4 Ferring Pharmaceuticals Oncology Injection Drug Products Offered
- 12.7.5 Ferring Pharmaceuticals Recent Development
- 12.8 Genzyme
- 12.8.1 Genzyme Corporation Information
- 12.8.2 Genzyme Description and Business Overview
- 12.8.3 Genzyme Sales, Revenue and Gross Margin (2015-2020)
- 12.8.4 Genzyme Oncology Injection Drug Products Offered
- 12.8.5 Genzyme Recent Development
- 12.9 Eli Lilly
- 12.9.1 Eli Lilly Corporation Information
- 12.9.2 Eli Lilly Description and Business Overview
- 12.9.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
- 12.9.4 Eli Lilly Oncology Injection Drug Products Offered
- 12.9.5 Eli Lilly Recent Development
- 12.10 Praecis Pharmaceuticals
- 12.10.1 Praecis Pharmaceuticals Corporation Information
- 12.10.2 Praecis Pharmaceuticals Description and Business Overview
- 12.10.3 Praecis Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 12.10.4 Praecis Pharmaceuticals Oncology Injection Drug Products Offered
- 12.10.5 Praecis Pharmaceuticals Recent Development
- 12.11 Taj Oncology
- 12.11.1 Taj Oncology Corporation Information
- 12.11.2 Taj Oncology Description and Business Overview
- 12.11.3 Taj Oncology Sales, Revenue and Gross Margin (2015-2020)
- 12.11.4 Taj Oncology Oncology Injection Drug Products Offered
- 12.11.5 Taj Oncology Recent Development
- 12.12 Debiopharm
- 12.12.1 Debiopharm Corporation Information
- 12.12.2 Debiopharm Description and Business Overview
- 12.12.3 Debiopharm Sales, Revenue and Gross Margin (2015-2020)
- 12.12.4 Debiopharm Products Offered
- 12.12.5 Debiopharm Recent Development
- 12.13 Alza
- 12.13.1 Alza Corporation Information
- 12.13.2 Alza Description and Business Overview
- 12.13.3 Alza Sales, Revenue and Gross Margin (2015-2020)
- 12.13.4 Alza Products Offered
- 12.13.5 Alza Recent Development
- 12.14 CordenPharma
- 12.14.1 CordenPharma Corporation Information
- 12.14.2 CordenPharma Description and Business Overview
- 12.14.3 CordenPharma Sales, Revenue and Gross Margin (2015-2020)
- 12.14.4 CordenPharma Products Offered
- 12.14.5 CordenPharma Recent Development
- 12.15 Pharmascience
- 12.15.1 Pharmascience Corporation Information
- 12.15.2 Pharmascience Description and Business Overview
- 12.15.3 Pharmascience Sales, Revenue and Gross Margin (2015-2020)
- 12.15.4 Pharmascience Products Offered
- 12.15.5 Pharmascience Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Oncology Injection Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Oncology Injection Drug Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Oncology Injection Drug. Industry analysis & Market Report on Oncology Injection Drug is a syndicated market report, published as Global and Japan Oncology Injection Drug Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of Oncology Injection Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
